Valeo SE
OTC:VLEEF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Valeo SE
OTC:VLEEF
|
FR |
|
A
|
Atara Biotherapeutics Inc
SWB:AT2
|
US |
|
O
|
Open Text Corp
XBER:OTX
|
CA |
|
A
|
Ascendis Pharma A/S
F:A71
|
DK |
|
Jacobs Engineering Group Inc
NYSE:J
|
US |
Wall St Price Targets
VLEEF Price Targets Summary
Valeo SE
According to Wall Street analysts, the average 1-year price target for VLEEF is 16.63 USD with a low forecast of 13.23 USD and a high forecast of 22 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is VLEEF's stock price target?
Price Target
16.63
USD
According to Wall Street analysts, the average 1-year price target for VLEEF is 16.63 USD with a low forecast of 13.23 USD and a high forecast of 22 USD.
What is the Revenue forecast for Valeo SE?
Projected CAGR
3%
Over the last 14 years, the compound annual growth rate for Revenue has been 5%. The projected CAGR for the next 3 years is 3%.
What is the Gross Profit forecast for Valeo SE?
Projected CAGR
6%
Over the last 14 years, the compound annual growth rate for Gross Profit has been 6%. The projected CAGR for the next 3 years is 6%.
What is the Operating Income forecast for Valeo SE?
Projected CAGR
10%
Over the last 14 years, the compound annual growth rate for Operating Income has been 2%. The projected CAGR for the next 3 years is 10%.
What is the Pre-Tax Income forecast for Valeo SE?
Projected CAGR
30%
Over the last 14 years, the compound annual growth rate for Pre-Tax Income has been -2%. The projected CAGR for the next 3 years is 30%.
What is the Net Income forecast for Valeo SE?
Projected CAGR
45%
Over the last 14 years, the compound annual growth rate for Net Income has been -5%. The projected CAGR for the next 3 years is 45%.
